The vast majority of prenatal genetic testing requires invasive sampling. However, this poses a risk to the fetus, so one must make a decision that weighs the desire for genetic information against the risk of an adverse outcome due to hazards of the testing process. These issues are not required to be coupled, and it would be desirable to discover genetic information about the fetus without incurring a health risk. Here we demonstrate that it is possible to non-invasively sequence the entire prenatal genome. Our results show that molecular counting of parental haplotypes in maternal plasma by shotgun sequencing of maternal plasma DNA allows the inherited fetal genome to be deciphered non-invasively. We also applied the counting principle directly to each allele in the fetal exome by performing exome capture on maternal plasma DNA before shotgun sequencing. This approach enables non-invasive exome screening of clinically relevant and deleterious alleles that were paternally inherited or had arisen as de novo germline mutations, and complements the haplotype counting approach to provide a comprehensive view of the fetal genome. Non-invasive determination of the fetal genome may ultimately facilitate the diagnosis of all inherited and de novo genetic disease.
At a glance
- Les acides nucléiques du plasma sanguin chez l’homme. C. R. Acad. Sci. Paris 142, 241–243 (1948) &
- Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am. J. Hum. Genet. 62, 768–775 (1998) et al.
- Genomics and perinatal care. N. Engl. J. Med. 366, 64–73 (2012) &
- Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc. Natl Acad. Sci. USA 105, 16266–16271 (2008) , , , &
- Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood. Clin. Chem. 57, 1042–1049 (2011) et al.
- Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obst. Gynecol. 119, 890–901 (2012) et al.
- DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet. Med. 14, 296–305 (2012) et al.
- DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet. Med. 13, 913–920 (2011) et al.
- Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am. J. Obstet. Gynecol. 204, 205.e1–211.e11 (2011) et al.
- Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. Br. Med. J. 342, c7401 (2011) et al.
- Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci. Transl. Med. 2, 61ra91 (2010) et al.
- In principle method for noninvasive determination of the fetal genome. Preprint at http://precedings.nature.com/documents/5373/version/1 (2010) &
- Non-paternity and prenatal genetic screening. Lancet 338, 869–871 (1991) &
- Measuring paternal discrepancy and its public health consequences. J. Epidemiol. Community Health 59, 749–754 (2005) , , &
- Whole-genome molecular haplotyping of single cells. Nature Biotechnol. 29, 51–57 (2011) , , &
- The 1000 Genomes Project Consortium. A map of human genome variation from population-scale sequencing. Nature 467, 1061–1073 (2010)
- A comparison of phasing algorithms for trios and unrelated individuals. Am. J. Hum. Genet. 78, 437–450 (2006) et al.
- Digital PCR provides sensitive and absolute calibration for high throughput sequencing. BMC Genomics 10, 116 (2009) , , &
- Performance comparison of exome DNA sequencing technologies. Nature Biotechnol. 29, 908–914 (2011) et al.
- Detection and quantification of rare mutations with massively parallel sequencing. Proc. Natl Acad. Sci. USA 108, 9530–9535 (2011) , , , &
- Supplementary Information (5.8M)
This file contains Supplementary Text, Supplementary Tables 1-3 and Supplementary Figures 1-14.